Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Groupe Crit | EU:CEN | Euronext | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 65.60 | 65.40 | 74.80 | 0.00 | 07:15:18 |
Hot Features
Premium
RNS Number:5293Q
CeNeS Pharmaceuticals PLC
03 October 2003
CENES PHARMACEUTICALS PLC (the "Company")
Director(s) Shareholding
The Company was today informed that Mr Ronald Irwin, a Non-executive Director of
the Company, yesterday purchased 175,000 ordinary shares of 1p each in the
Company ("Ordinary Shares") for 3.85 pence per share.
Following this purchase Mr Irwin has a beneficial interest in 211,000 Ordinary
Shares, representing 0.01 per cent of the current issued share capital of the
Company.
3 October 2003
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSUOSVRONRRRAA
1 Year Groupe Crit Chart |
1 Month Groupe Crit Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
